Search results
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 4 days agoShares of Bristol Myers Squibb (NYSE: BMY) were down 8.3% as of 11:19 a.m. ET on Thursday. The sell-off came after the big drugmaker announced its...
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 4 days agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...
Bristol-Myers Squibb Co. (BMY) Shares Soar Above 1-Year High – News Heater
NewsHeater· 7 days agoBristol-Myers Squibb Co. (NYSE: BMY)’s stock price has soared by 1.30 in relation to previous closing price of 48.30. The Motley Fool reported 2024-04-20 that Bristol Myers has an uncertain ...
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
InvestorPlace· 4 days agoBristol-Myers Squibb (NYSE:BMY) layoffs are a hot topic on Thursday after the biopharmaceutical...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 3 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 days agoMany top healthcare stocks provide investors with long-term stability, promising growth prospects, and in some cases even a dividend. Yet, investors...
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Benzinga via Yahoo Finance· 3 days agoThursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion,...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 4 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
Bristol-Myers Squibb (NYSE:BMY) Forecasted to Post Q3 2024 Earnings of $1.67 Per Share
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Zacks Research cut their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday ...
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply...
Morningstar· 7 days agoBristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More ...